These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

996 related articles for article (PubMed ID: 22161409)

  • 21. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
    Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
    Cates CJ; Wieland LS; Oleszczuk M; Kew KM
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
    Lasserson TJ; Ferrara G; Casali L
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD004106. PubMed ID: 22161385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.
    Kew KM; Karner C; Mindus SM; Ferrara G
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD009019. PubMed ID: 24343671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.
    Fukuda N; Horita N; Kaneko A; Goto A; Kaneko T; Ota E; Kew KM
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD012066. PubMed ID: 37276335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma.
    Kew KM; Evans DJ; Allison DE; Boyter AC
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011438. PubMed ID: 26031392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
    Cates CJ; Karner C
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis.
    Goyal V; Chang AB
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD010327. PubMed ID: 24913725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
    Kew KM; Dahri K
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease.
    Karner C; Cates CJ
    Cochrane Database Syst Rev; 2012 Apr; 4(4):CD008989. PubMed ID: 22513969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
    Kew KM; Mavergames C; Walters JA
    Cochrane Database Syst Rev; 2013 Oct; (10):CD010177. PubMed ID: 24127118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children.
    Ni Chroinin M; Lasserson TJ; Greenstone I; Ducharme FM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007949. PubMed ID: 19588447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease.
    Nannini LJ; Cates CJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006829. PubMed ID: 17943918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
    Nannini L; Cates CJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2004; (3):CD003794. PubMed ID: 15266502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease.
    Nannini LJ; Cates CJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006826. PubMed ID: 17943917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
    Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
    Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
    Oba Y; Keeney E; Ghatehorde N; Dias S
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.
    Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008532. PubMed ID: 21412920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled corticosteroids for stable chronic obstructive pulmonary disease.
    Yang IA; Clarke MS; Sim EH; Fong KM
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD002991. PubMed ID: 22786484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.